Bio-Fab
A bio-fabrication lab (Fab-Lab) providing 3D bioprinting and additive manufacturing capabilities for biological research, enabling scientists and students to create complex cellular constructs for tissue engineering and regenerative medicine.
- CEO / Founder
- Fabio Riccobono
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $210K
- Latest Round
- Seed
Technology & Products
Key Products
3D bioprinting and additive manufacturing capabilities for biological research; creation of complex cellular constructs for tissue engineering and regenerative medicine
Technological Advantage
Verified advantage: Access to specialized 3D bioprinting equipment and expertise within a CNRS (French National Centre for Scientific Research) facility, enabling cutting-edge biological research. Defensible through institutional affiliation and network effects.
Differentiation
Value Proposition
Provides access to advanced 3D bioprinting technology and interdisciplinary collaboration in a Fab-Lab environment, accelerating biological research and innovation in tissue engineering and regenerative medicine.
How They Differentiate
As a research-focused Fab-Lab within a public institution (CNRS), it differs from commercial bioprinting companies by prioritizing open collaboration, education, and public research over commercial product development.
Market & Competition
Target Customers
Research scientists, academic institutions, biology students, and public research organizations in the field of biology and biotechnology.
Industry Verticals
Biotechnology; Medical Research; Education
Competitors
Regemat 3D; Particle3D; IamFluidics
Growth & Milestones
Growth Metrics
Bio-Fab appears connected to the French bioprinting ecosystem rather than a standalone commercial entity with full corporate data; it operates as a research service under CNRS without private funding tracked publicly.
Major Milestones
Founded in 2005, activity started in 2006 at IRBM; provides DNA sequencing and laboratory services; certified UNI EN ISO 9001:2015